Article
GSK's ViiV says study shows its long-acting HIV shot as effective as Gilead's daily pill
Rating:
0.0
Views:
57
Likes:
1
Library:
1
British drugmaker GSK's HIV treatment division, ViiV Healthcare, published data on Wednesday showing its long-acting HIV injection is as effective as the market-leading daily pill made by Gilead Sciences Inc .
Rate This Post
Rate The Educational Value
Rate The Ease of Understanding and Presentation
Interesting or Boring? Rate the Entertainment Value